Atorvastatin Treatment for Atrial Fibrillation Reduces Serum High-Sensitivity C-Reactive Protein Levels

about

Atorvastatin Treatment for Atrial Fibrillation Reduces Serum High-Sensitivity C-Reactive Protein Levels

Item

http://www.wikidata.org/entity/Q35851578

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Atorvastatin Treatment for Atr ...... vity C-Reactive Protein Levels

@ast

Atorvastatin Treatment for Atr ...... vity C-Reactive Protein Levels

@en

type

Item

label

Atorvastatin Treatment for Atr ...... vity C-Reactive Protein Levels

@ast

Atorvastatin Treatment for Atr ...... vity C-Reactive Protein Levels

@en

prefLabel

Atorvastatin Treatment for Atr ...... vity C-Reactive Protein Levels

@ast

Atorvastatin Treatment for Atr ...... vity C-Reactive Protein Levels

@en

P1476

Atorvastatin Treatment for Atr ...... vity C-Reactive Protein Levels

@en

P2093

Fang-Cheng Su

http://www.w3.org/2001/XMLSchema#string

Feng Yin

http://www.w3.org/2001/XMLSchema#string

Feng-Hua Xue

http://www.w3.org/2001/XMLSchema#string

Hong-Yue Gu

http://www.w3.org/2001/XMLSchema#string

Jing Zhu

http://www.w3.org/2001/XMLSchema#string

Li Jiang

http://www.w3.org/2001/XMLSchema#string

Ming-Yu Shi

http://www.w3.org/2001/XMLSchema#string

Shao-Xia Sun

http://www.w3.org/2001/XMLSchema#string

Shi-Chao Teng

http://www.w3.org/2001/XMLSchema#string

Xi-Dong Li

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmacological Approaches in the Treatment of Atrial Fibrillation

Arrhythmia-provoking factors and symptoms at the onset of paroxysmal atrial fibrillation: a study based on interviews with 100 patients seeking hospital assistance

Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses

Quantifying the impact of between-study heterogeneity in multivariate meta-analyses

Heart disease and stroke statistics--2012 update: a report from the American Heart Association

2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association

Comparison of two methods to detect publication bias in meta-analysis

Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies.

Atorvastatin and celecoxib in combination inhibits the progression of androgen-dependent LNCaP xenograft prostate tumors to androgen independence

Longitudinal tracking of left atrial diameter over the adult life course: Clinical correlates in the community.

P304

402481

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

meta-analysis

P356

10.1155/2015/402481

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

2015

http://www.w3.org/2001/XMLSchema#string

P577

2015-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281529328

http://www.w3.org/2001/XMLSchema#string

P698

26229958

http://www.w3.org/2001/XMLSchema#string

P932

4502280

http://www.w3.org/2001/XMLSchema#string